Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 1;22(5):244-249.
doi: 10.1530/alphapsychiatry.2021.21157. eCollection 2021 Sep.

Association of Temporolimbic Volumes with Treatment Response to Antipsychotic Medication for Delusion in Patients with Alzheimer's Disease

Hee-Jeong Jeong  1   2 , Hwagyu Suh  1   2 , Young-Min Lee  1   2 , Hye Kyung Park  1   2 , Hak-Jin Kim  3 , Kyongjune Pak  4 , Kyung-Un Choi  2   5 , Young-In Chung  6
Affiliations

Association of Temporolimbic Volumes with Treatment Response to Antipsychotic Medication for Delusion in Patients with Alzheimer's Disease

Hee-Jeong Jeong et al. Alpha Psychiatry. .

Abstract

Objective: This study investigated the association between gray matter volume and the treatment response to antipsychotic medication in patients with Alzheimer's disease (AD).

Methods: We included 26 AD patients with delusions from the Memory Impairment Center of the Pusan National University Hospital in South Korea. All participants underwent baseline brain magnetic resonance imaging and took risperidone as an antipsychotic medication for 6 weeks. Gray matter volumes were measured using voxel-based morphometry at baseline. Treatment response with respect to delusional symptoms was defined as the change in delusion item scores in the Korean version of the Neuropsychiatry Inventory (K-NPI), from baseline to 6 weeks later. A voxel-based multiple linear regression model integrated with statistical parametric mapping was used to investigate the association between gray matter volume and treatment response after controlling for covariates.

Results: The treatment response was significantly positively correlated with gray matter volume in the temporal lobe (both the fusiform gyri and the left superior and inferior temporal gyri) and the limbic system (the left parahippocampal gyrus and left amygdala) after controlling for age, sex, education level, total intracranial volume, risperidone dosage, baseline Korean version of the Mini-Mental Status Examination scores, and baseline K-NPI scores for the delusion and non-delusion domains (P < .001, uncorrected, KE > 100 voxels).

Conclusion: Our findings suggest that specific gray matter volumes, including those of the temporal region and the limbic system, may affect treatment response to antipsychotic medication in terms of delusional symptoms in patients with AD.

Keywords: Alzheimer’s disease; Gray matter; delusions; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflict of interest to declare.

Figures

Figure 1.
Figure 1.
Flowchart showing the criteria used to exclude participants from the study and reach final sample size.
Figure 2.
Figure 2.
Regions with positive significant association between gray matter volumes and treatment response of delusion after 6 weeks of treatment with risperidone in 21 AD patients with psychosis (P < .001, uncorrected, KE > 100 voxels). The multiple regression model included age, gender, years of education, total intracranial volume, K-MMSE scores, baseline K-NPI delusion scores, and K-NPI non-delusion scores as covariate of no interest. AD, Alzheimer’s disease; K-MMSE, the Korean version of the Mini-Mental State Exam; K-NPI, the Korean version of the Neuropsychiatry Inventory.
See this image and copyright information in PMC

References

    1. Ahn HJ, Chin J, Park A. et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci. 2010;25(7):1071–1076.. 10.3346/jkms.2010.25.7.1071) - DOI - PMC - PubMed
    1. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc. 1990;38(5):553–563.. 10.1111/j.1532-5415.1990.tb02407.x) - DOI - PubMed
    1. Hsu WT, Esmaily-Fard A, Lai CC. et al. Antipsychotics and the risk of ­cerebrovascular accident: a systematic review and meta-analysis of observational studies. J Am Med Dir Assoc. 2017;18(8):692–699.. 10.1016/j.jamda.2017.02.020) - DOI - PubMed
    1. Yang C, Hao Z, Tian J. et al. Does antipsychotic drug use increase the risk of long term mortality? A systematic review and meta-analysis of observational studies. Oncotarget. 2018;9(19):15101–15110.. 10.18632/oncotarget.24120) - DOI - PMC - PubMed
    1. Bruen PD, McGeown WJ, Shanks MF, Venneri A. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain. 2008;131(9):2455–2463.. 10.1093/brain/awn151) - DOI - PubMed

LinkOut - more resources